Arrowhead Pharmaceuticals
Earnings Date & Report
Last updated:
Arrowhead Pharmaceuticals’s last earnings date was on 5 Feb 2024.
Arrowhead Pharmaceuticals stock Earnings report, Estimates & History
| 2019-08-05 | 0.2697 | 0.21 |
|---|---|---|
| 2019-11-25 | 0.1464 | 0.11 |
| 2020-02-05 | -0.12605 | -0.03 |
| 2020-05-07 | -0.36734 | -0.2 |
| 2020-08-05 | -0.14569 | -0.13 |
| 2020-11-23 | -2.94005 | -0.48 |
| 2021-02-04 | -0.7393 | -0.2 |
| 2021-05-04 | -0.51485 | -0.26 |
| 2021-08-05 | -0.42624 | -0.29 |
| 2021-11-22 | -3.52867 | -0.61 |
| 2022-02-02 | -0.80538 | -0.6 |
| 2022-05-10 | -2.0753 | 0.41 |
| 2022-08-04 | -0.91412 | -0.68 |
| 2022-11-28 | -3.96552 | -0.81 |
| 2023-02-06 | -1.12858 | -0.39 |
| 2023-05-02 | 0.45 | 0.45 |
Estimated - a value of Apple’s earnings per share estimated by analysts based on its past and current financial statements.
Reported - a real value of Apple’s earnings per share reported by the company.
Arrowhead Pharmaceuticals stock earnings history by quarter
| Date | Estimated EPS | Reported EPS | Estimated revenue | Actual revenue | Earnings call | |
|---|---|---|---|---|---|---|
| 5 Feb 2024 | N/A | N/A | N/A | N/A | N/A | Earnings Call Transcript |
| 27 Nov 2023 | N/A | N/A | N/A | N/A | N/A | |
| 2 Aug 2023 | N/A | -$0.72 | N/A | 45.79M | N/A | |
| 2 May 2023 | Matched | $0.45 | $0.45 | 45.48M | 146.26M | Earnings Call Transcript |
| 6 Feb 2023 | Beat | -$1.13 | -$0.39 | N/A | 62.54M | Earnings Call Transcript |
| 31 Dec 2022 | N/A | N/A | -$0.39 | N/A | 62.54M | |
| 28 Nov 2022 | Beat | -$3.97 | -$0.81 | N/A | 31.57M | Earnings Call Transcript |
| 4 Aug 2022 | Beat | -$0.91 | -$0.68 | N/A | 32.41M | Earnings Call Transcript |
| 10 May 2022 | Beat | -$2.08 | $0.41 | 973.44M | 151.80M | Earnings Call Transcript |
| 2 Feb 2022 | Beat | -$0.81 | -$0.6 | 110.61M | 27.43M | Earnings Call Transcript |
| 22 Nov 2021 | Beat | -$3.53 | -$0.61 | 37.23M | 38.28M | Earnings Call Transcript |
| 5 Aug 2021 | Beat | -$0.43 | -$0.29 | 37.52M | 45.89M | Earnings Call Transcript |
| 4 May 2021 | Beat | -$0.51 | -$0.26 | 37.7M | 32.81M | Earnings Call Transcript |
| 4 Feb 2021 | Beat | -$0.74 | -$0.2 | 79.46M | 21.30M | Earnings Call Transcript |
| 23 Nov 2020 | Beat | -$2.94 | -$0.48 | 41.21M | 7.63M | Earnings Call Transcript |
| 5 Aug 2020 | Beat | -$0.15 | -$0.13 | 25.26M | 27.37M | Earnings Call Transcript |
| 7 May 2020 | Beat | -$0.37 | -$0.2 | 15.88M | 23.52M | Earnings Call Transcript |
| 5 Feb 2020 | Beat | -$0.13 | -$0.03 | 9.81M | 29.45M | Earnings Call Transcript |
| 25 Nov 2019 | Missed | $0.15 | $0.11 | 62.97M | 43.29M | Earnings Call Transcript |
| 5 Aug 2019 | Missed | $0.27 | $0.21 | 58.96M | 42.69M | Earnings Call Transcript |
Arrowhead Pharmaceuticals Earnings report FAQs
When is Arrowhead Pharmaceuticals's next Earnings date?
The company has not set the next earnings date yet. The latest Arrowhead Pharmaceuticals's earnings date was on 6 Feb 2023.
What are earnings?
Earnings are the net income of a company after all taxes and expenses have been deducted. They are the main figure for determining the price of a company's shares.
What does EPS stand for?
EPS stands for earnings per share, which is the basic measure of a company's earnings. It indicates how much money each share earned for the company.
How to calculate earnings per share?
Earnings per share (EPS) can be calculated by dividing a company's net income by the number of common shares outstanding. If the company pays preferred dividends, they are first subtracted from the company’s net income.
Formula:
What is earnings per share estimate?
Earnings estimate is analysts’ prediction of a company’s earnings value in the next quarter or fiscal year based on past and current financial statements of a company. It is an important indicator for both current and future investors.